Reducing the amount of acetaminophen in opioids and combination medications appears to be safe for the liver.

Published Date: 13 Mar 2023

The United States Food and Drug Administration (FDA) has ordered a ban on the use of acetaminophen in combination with acetaminophen and opioids...

Read Full News

Latest News

Sugars on immune cells, not just blood vessel walls, may regulate the inflammatory disease process

New research has updated the understanding of how sugars, known as glycans, help immune cells move into the skin in the inflammatory disease, psoriasis.

Nerve injuries can affect the entire immune system, study finds

Nerve injuries can have long-lasting effects on the immune system that appear to differ between males and females, according to preclinical research from McGill University.

From blood to solid tumors: A new way to power up CAR T cell therapy

Chimeric Antigen Receptor (CAR) T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers. Solid tumors, which account for around 90% of all adult cancers, ...

Poison ivy, poison oak and poison sumac rash

When skin touches poison ivy, poison oak or poison sumac plants, the oils from the plant can cause a rash. This rash can be very uncomfortable, itchy and unsightly. The medical name for this rash is contact dermatitis. Since ...

People abused by intimate partners have worse asthma—researchers are still investigating this surprising link

Asthma is a common, serious and difficult-to-manage chronic health condition. In the U.S., 1 in 7 people are diagnosed with asthma, and that number is rising.

Antibody therapy foils pancreatic cancer's sugar-based disguise to reawaken immune system

Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine scientists have uncovered a novel explanation for that resistance: Pancreatic tumors use a sugar-based ...

Todays Updates

Data-driven risk stratification guides childhood brain tumor treatment, reducing side effects

By analyzing data from three clinical trials treating children with the brain tumor medulloblastoma, scientists at St. Jude Children's Research Hospital have designed an approach to safely reduce therapy, thereby lowering ...

Radiotherapy after mastectomy can be avoided, study finds

Radiotherapy can be safely omitted as a treatment for many breast cancer patients who have had a mastectomy and are taking anti-cancer drugs, a study shows.

Advanced breast cancer patients living longer thanks to improvements in treatment and care

People diagnosed with advanced breast cancer in 2025 can expect to live for an extra six or seven months, compared to the average survival time for patients diagnosed in 2011, according to a major study of patient data in ...

Todays Updates

Data-driven risk stratification guides childhood brain tumor treatment, reducing side effects

By analyzing data from three clinical trials treating children with the brain tumor medulloblastoma, scientists at St. Jude Children's Research Hospital have designed an approach to safely reduce therapy, thereby lowering ...

Radiotherapy after mastectomy can be avoided, study finds

Radiotherapy can be safely omitted as a treatment for many breast cancer patients who have had a mastectomy and are taking anti-cancer drugs, a study shows.

Advanced breast cancer patients living longer thanks to improvements in treatment and care

People diagnosed with advanced breast cancer in 2025 can expect to live for an extra six or seven months, compared to the average survival time for patients diagnosed in 2011, according to a major study of patient data in ...

Latest News

New research has updated the understanding of how sugars, known as glycans, help immune cells move into the skin in the inflammatory disease, psoriasis.

Nerve injuries can have long-lasting effects on the immune system that appear to differ between males and females, according to preclinical research from McGill University.

Chimeric Antigen Receptor (CAR) T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers. Solid tumors, which account for around 90% of all adult cancers, ...

When skin touches poison ivy, poison oak or poison sumac plants, the oils from the plant can cause a rash. This rash can be very uncomfortable, itchy and unsightly. The medical name for this rash is contact dermatitis. Since ...

Asthma is a common, serious and difficult-to-manage chronic health condition. In the U.S., 1 in 7 people are diagnosed with asthma, and that number is rising.

Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine scientists have uncovered a novel explanation for that resistance: Pancreatic tumors use a sugar-based ...

News All Time

Women have higher odds of chronic rhinosinusitis without nasal polyps

Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men, according to a study published online Oct. 23 in JAMA Otolaryngology-Head & Neck Surgery.

Enhancing the body's 'first responder' cells may boost immune therapy for cancer

Mayo Clinic researchers have identified a specific immune cell that can be targeted to give a boost to standard immunotherapies for cancer. Two research teams, working collaboratively but using distinct approaches, found ...

Injectable drug helps asthma patients clear mucus-clogged airways

An anti-inflammation injectable drug can reduce mucus buildup and improve breathing among asthma patients, a new clinical trial says.

Chemotherapy nerve damage linked to immune cell stress pathway activation

Scientists at Wake Forest University School of Medicine, in collaboration with researchers at Weill Cornell Medicine, have made a breakthrough in understanding why many cancer patients develop nerve damage after chemotherapy. ...

FDA approves Tezspire for chronic rhinosinusitis with nasal polyps

The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in adult and pediatric patients ...

In-surgery radiation cuts pancreatic cancer return

Using targeted radiation during surgery—referred to as intraoperative radiation—to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins have been able to reduce ...

Clinical trial presents promising DNA-encoded therapy for long-lasting protection against COVID-19

A new way to deliver protective antibodies against COVID-19 was tested in a Phase I clinical trial. Instead of injecting pre-made antibodies into patients, this approach encouraged the body to produce its own antibodies to ...

AI models help pinpoint key neoantigens for personalized skin cancer vaccines

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that contain features of good candidates ...

Custom-designed protein receptors help T cells target solid tumors more effectively

Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, especially those equipped with chimeric antigen receptors (CAR-T cells), have revolutionized cancer ...

Potential cancer outcome differences among psoriasis biologics found

Copenhagen University Hospital–Herlev and Gentofte led a nationwide registry study that the authors claim shows a "pattern suggesting" a lower five-year risk of any first cancer (excluding non-melanoma skin cancer) with ...

Promising new drug combination for melanoma patients resistant to treatment

Melanoma is the most common form of skin cancer, but for patients with advanced melanoma who no longer respond to standard immunotherapy, treatment options are painfully limited. Vanderbilt researchers led by Professor Emerita ...

Influenza A-infected volunteers display different patterns of expelling viruses into environment

Late in the Middle Ages, Italian stargazers gave a name to the annual contagion that rolled around each year like clockwork. It was a name that stuck, and to this day is known as influenza.

BiTE-based immunotherapy strategy could point the way to a breakthrough for ovarian cancer patients

Results of a study led by researchers at Roswell Park Comprehensive Cancer Center show that combining two types of immunotherapy—engineered T cells that secrete bispecific T cell engagers (BiTEs) and an immune checkpoint ...

Localized IL-12 delivery reshapes CAR-T safety in solid tumors

An international collaboration of researchers, including Imperial College London and UCLA, has developed a collagen-binding interleukin 12 strategy that lets CAR-T cells treat prostate cancer in mice while curbing previously ...

Breastfeeding linked to lasting immune protection against breast cancer

A team of researchers led by Peter Mac's Professor Sherene Loi has uncovered how having children and breastfeeding reduces a woman's long-term risk of breast cancer.

Improving immunotherapy responses to fight cancer with dual therapies

Promising study in dual inhibition of PD1 and macrophage migration inhibitory factor

Recommended News For You

Understudied mental health challenges among caregivers of cancer patients: A call for targeted support

Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.

Nuclear missile workers are contracting cancer: They blame the bases

Mortality up for children with leukemia from lowest SES neighborhoods

Elder Abuse: Red Flags to Look Out For While Receiving Care.

Medical Journal March 28, 2023

In cancer survivors, loneliness is associated with a higher risk of death.

Recommended Articles For You

Hemoglobin C: Understanding its Role in Sickle Cell Disease 

Single-Cell Lineage Tracing in Hematology: Decoding the Cellular Blueprint of Blood Disorders 

TAR-200 in Bladder Cancer: Precision Drug Delivery Driving Oncology Advances 

Carboplatin Treatment: What You Need to Know About Side Effects and Efficacy  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Many patients learn they could have cancer in the emergency department

2.

Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.

3.

The FDA approves alexinib as an adjuvant treatment for non-small cell lung cancer.

4.

A novel blood test may enable the early identification of common, fatal cancers.

5.

New drug combination shows good results in patients with HPV-negative head and neck cancer

1.

Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL

2.

Role of Type I Interferons and KDM1B in Driving Cancer Stemness and Therapeutic Evasion

3.

Dexamethasone and Life Expectancy After Pediatric Stem Cell Transplant

4.

AI-Powered Rehabilitation: A Game Changer for Hemophilia Management

5.

Lactic Acid-Linked lncRNAs in Wilms Tumor: Decoding the Tumor Microenvironment & Prognosis

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

2.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

3.

Navigating the Complexities of Ph Negative ALL - Part II

4.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot